P613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANISM FOLLOWING BTKI THERAPY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA.
E. Kennedy,
S. Mitchell,
T. A. Burley,
T. Liloglou,
R. Johnston,
I. Ashworth,
D. Bak-Blaz,
K. Chamberlain,
E. Ladikou,
S. Mackay,
C. Pepper,
A. G. Pepper June, 2022